Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale "PFO-HUG"


Phase N/A Results N/A

Summary of Purpose

Following a cryptogenic stroke, many patients are nowadays treated with the percutaneous closure of a patent foramen ovale (PFO), assuming that the aetiology of the stroke is secondary to a paradoxical embolism. After the PFO closure procedure a dual antiplatelet regimen is often prescribed for 3-6 months and several cardiologic and neurologic follow-up exams are scheduled in the first 12 months of follow-up....

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 August 2012.

1 Jan 2001 22 Jun 2010 Unavailable Unavailable 1 Aug 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample